GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avid Bioservices Inc (STU:TEHN) » Definitions » EV-to-EBITDA

Avid Bioservices (STU:TEHN) EV-to-EBITDA : -90.09 (As of May. 14, 2024)


View and export this data going back to . Start your Free Trial

What is Avid Bioservices EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Avid Bioservices's enterprise value is €671.7 Mil. Avid Bioservices's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 was €-7.5 Mil. Therefore, Avid Bioservices's EV-to-EBITDA for today is -90.09.

The historical rank and industry rank for Avid Bioservices's EV-to-EBITDA or its related term are showing as below:

STU:TEHN' s EV-to-EBITDA Range Over the Past 10 Years
Min: -298.77   Med: -3.55   Max: 979.12
Current: -92.49

During the past 13 years, the highest EV-to-EBITDA of Avid Bioservices was 979.12. The lowest was -298.77. And the median was -3.55.

STU:TEHN's EV-to-EBITDA is ranked worse than
100% of 463 companies
in the Biotechnology industry
Industry Median: 9.32 vs STU:TEHN: -92.49

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-14), Avid Bioservices's stock price is €8.15. Avid Bioservices's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 was €-0.257. Therefore, Avid Bioservices's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Avid Bioservices EV-to-EBITDA Historical Data

The historical data trend for Avid Bioservices's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avid Bioservices EV-to-EBITDA Chart

Avid Bioservices Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -91.58 -45.49 79.31 44.82 108.55

Avid Bioservices Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 98.42 108.55 117.70 915.16 -75.85

Competitive Comparison of Avid Bioservices's EV-to-EBITDA

For the Biotechnology subindustry, Avid Bioservices's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avid Bioservices's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avid Bioservices's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Avid Bioservices's EV-to-EBITDA falls into.



Avid Bioservices EV-to-EBITDA Calculation

Avid Bioservices's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=671.733/-7.456
=-90.09

Avid Bioservices's current Enterprise Value is €671.7 Mil.
Avid Bioservices's EBITDA for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-7.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avid Bioservices  (STU:TEHN) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Avid Bioservices's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=8.15/-0.257
=At Loss

Avid Bioservices's share price for today is €8.15.
Avid Bioservices's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.257.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Avid Bioservices EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Avid Bioservices's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Avid Bioservices (STU:TEHN) Business Description

Traded in Other Exchanges
Address
14191 Myford Road, Tustin, CA, USA, 92780
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries.

Avid Bioservices (STU:TEHN) Headlines

No Headlines